Cesamet (Meda Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Cesamet drug offered from Meda Pharmaceuticals Inc.. This Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Meda Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Nabilone |
SUBSTANCE NAME: | NABILONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-03-01 |
END MARKETING DATE: | 0000-00-00 |
Cesamet HUMAN PRESCRIPTION DRUG Details:
Item Description | Cesamet from Meda Pharmaceuticals Inc. |
LABELER NAME: | Meda Pharmaceuticals Inc. |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 1(mg/1) |
START MARKETING DATE: | 2010-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0037-1221_70568880-5589-40c0-88f8-1721eef4a8a0 |
PRODUCT NDC: | 0037-1221 |
APPLICATION NUMBER: | NDA018677 |
Other NABILONE Pharmaceutical Manufacturers / Labelers: